FDA Inspection 1177970 — Eurofins BioPharma Product Testing Australia Pty Ltd.
The FDA completed an inspection of Eurofins BioPharma Product Testing Australia Pty Ltd. on Jul 27, 2022 in Dandenong South. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 27, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dandenong South (Australia)